Real World Evidence: A new approach to approve medical products for children

by Jeongpyo Hongfigures by Xiaomeng Hanedited by Sarah Kalinowski A little boy is in the hospital to fix his leg. His surgeon uses spinal rods developed for adults to fix the little boy’s leg as it is the only thing that really fits. Since the rod was developed for an adult spine, its clinical safety and effectiveness in the legs of children – with considerations … Continue reading Real World Evidence: A new approach to approve medical products for children

Racism and Exploitation in Phase I Clinical Trials

By Mary May Many people regard participating in clinical trials as an altruistic act that could help save lives. Most people, however, are unaware of who actually participates in the earliest stage of trials performed in humans. The healthy people who participate in Phase I clinical trials for the majority of drugs in the United States are most likely low income, Black or Hispanic, and … Continue reading Racism and Exploitation in Phase I Clinical Trials

Cancer Vaccines: How scientists are turning cancer against itself

by Cathy Gutierrez figures by Lillian Horin “The history of cancer vaccines is a history of failure.” This is the leading sentence of a 2005 article that summarized the history of cancer vaccines. Cancer vaccines have long been the Holy Grail of cancer research. For centuries, scientists have been devising ways to train the body to destroy tumors. Despite the success of early preventive cancer … Continue reading Cancer Vaccines: How scientists are turning cancer against itself

Heart Disease Drug Faces Biggest Test Yet

We just learned a lot more about a drug called Repatha, one of the newest weapons in the war against heart disease.  Heart-related diseases are the leading cause of death worldwide, accounting for over 30% of global deaths.  One of the major physiological warning signs of heart disease is “bad” cholesterol (LDL), which can clog arteries and increase the risk of heart attack and stroke. … Continue reading Heart Disease Drug Faces Biggest Test Yet